# OnCo record orion-orion-pharma (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/orion-orion-pharma/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "orion-orion-pharma" ;
  schema:name "Orion, Orion Pharma"@en ;
  schema:alternateName "Orion Corporation, Orion Pharma"@en ;
  schema:description "Orion, Orion Pharma is a Finland-based pharmaceutical company running 4 late-stage cancer trials of ODM-212, ODM-216 and sotorasib in mesothelioma, pancreatic ductal adenocarcinoma and non-small-cell lung cancer."@en ;
  schema:url <https://onco.cc/companies/orion-orion-pharma/>, <https://www.orionpharma.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.orionpharma.com>, <https://clinicaltrials.gov/search?lead=Orion%20Corporation%2C%20Orion%20Pharma> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "FI" ;
  onco:cancers <https://onco.cc/cancers/mesothelioma/>, <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/prostate/> ;
  onco:trials <https://onco.cc/trials/nct06725758/>, <https://onco.cc/trials/nct07805252/>, <https://onco.cc/trials/nct07563738/>, <https://onco.cc/trials/nct03436485/> .